Huaan Securities Co., Ltd. (SHA:600909)

Sage Therapeutics Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-	1,486	1,274	1,182	1,424	1,268
Depreciation & Amortization, Total	-	182.38	205.01	178.87	156.42	52.4
Gain (Loss) On Sale of Investments	-	-551.8	-433.17	355.43	-176.54	87.6
Change in Accounts Receivable	-	-1,534	-1,075	1,837	-6,598	-206.18
Change in Accounts Payable	-	14,779	-151.99	-1,574	8,503	815.5
Other Operating Activities	-	875.43	779.92	547.95	852.66	749.17
Operating Cash Flow	-	4,641	-4,972	-215.33	1.27	-667.96
Capital Expenditures	-	-177.99	-327.7	-294.53	-229.04	-505.9
Investment in Securities	-	-383.65	-205.59	-491.51	-396.81	-505.55
Other Investing Activities	-	-	29.77	14.57	12.98	-
Investing Cash Flow	-	-560.87	-458.45	-770.11	-612.18	-1,010
Long-Term Debt Issued	-	25,322	14,786	10,793	11,911	15,200
Long-Term Debt Repaid	-	-18,276	-10,364	-9,639	-10,649	-8,889
Net Debt Issued (Repaid)	-	7,046	4,422	1,154	1,262	6,312
Issuance of Common Stock	-	-	-	-	3,962	-
Repurchase of Common Stock	-	-93.1	-	-	-	-
Common Dividends Paid	-	-1,092	-919.64	-898.95	-861.39	-752.31
Other Financing Activities	-	-15.7	-42	-62.64	-154.59	-28.84
Financing Cash Flow	-	5,845	3,461	192.26	4,208	5,531
Foreign Exchange Rate Adjustments	-	7.82	6.03	22.14	-3.78	-1.73
Net Cash Flow	-	9,933	-1,964	-771.05	3,593	3,851
Free Cash Flow	-	4,463	-5,300	-509.86	-227.77	-1,174
Free Cash Flow Margin	-	98.49%	-147.29%	-16.14%	-6.64%	-35.03%
Free Cash Flow Per Share	-	0.90	-1.08	-0.10	-0.05	-0.32
Cash Interest Paid	-	754.51	727.82	789	913.9	587.19
Cash Income Tax Paid	-	394.23	442.48	658.42	701.75	440.2

Updated Jan 26, 2025. Source: S&P Global Market Intelligence. Capital Markets template. Financial Sources.